Correction to: DNA methylation signature is prognostic of choroid plexus tumor aggressiveness.

Autor: Pienkowska M; Genetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada., Choufani S; Genetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada., Turinsky AL; Genetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada.; Center for Computational Medicine, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada., Guha T; Genetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada., Merino DM; Friends of Cancer Research, 1800 M Street, NW, Suite 1050 South, Washington, DC, 20036, USA., Novokmet A; Genetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada., Brudno M; Genetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada.; Center for Computational Medicine, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada.; Department of Computer Science, University of Toronto, 40 St. George Street, Toronto, Ontario, M5S 2E4, Canada., Weksberg R; Genetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada.; Division of Clinical and Metabolic Genetics, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada.; Department of Pediatrics, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada., Shlien A; Genetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada.; Paediatric Laboratory Medicine, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada., Hawkins C; Genetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada.; Paediatric Laboratory Medicine, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada., Bouffet E; Division of Hematology/Oncology, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada.; Department of Pediatrics, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada., Tabori U; Genetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada.; Division of Hematology/Oncology, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada.; Department of Pediatrics, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada., Gilbertson RJ; Department of Oncology, Cambridge Cancer Center, Robinson Way, Cambridge, CB2 0RE, England., Finlay JL; Neuro-Oncology Program, Nationwide Children's Hospital and The Ohio State University, 700 Children's Dr, Columbus, OH, 43205, USA., Jabado N; Division of Hematology/Oncology, Montreal Children's Hospital of the McGill University Health Centre (RI-MUHC), 1001, Decarie Blvd, Montreal, Québec, H4A 3 J1, Canada., Thomas C; Institute of Neuropathology, University Hospital Münster, 48149, Münster, Germany., Sill M; Hopp Children's Cancer Center at the NCT Heidelberg (KiTZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Capper D; Department of Neuropathology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, Invalidenstrasse 80, 10117, Berlin, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Hasselblatt M; Institute of Neuropathology, University Hospital Münster, 48149, Münster, Germany., Malkin D; Genetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada. david.malkin@sickkids.ca.; Division of Hematology/Oncology, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada. david.malkin@sickkids.ca.; Department of Pediatrics, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada. david.malkin@sickkids.ca.; Department of Medical Biophysics, University of Toronto, Princess Margaret Cancer Research Tower, MaRS Centre, 101 College Street, Toronto, Ontario, M5G 1 L7, Canada. david.malkin@sickkids.ca.
Jazyk: angličtina
Zdroj: Clinical epigenetics [Clin Epigenetics] 2019 Oct 21; Vol. 11 (1), pp. 144. Date of Electronic Publication: 2019 Oct 21.
DOI: 10.1186/s13148-019-0737-7
Abstrakt: After publication of the original article [1], authors have requested to add a 'J' as middle name for Richard Gilbertson. Hence, full name should be Richard J Gilbertson.
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje